Delivery Order SPE2DB22D3016-SPE2DB25FBKH0
- Not listed
- The Defense Logistics Agency awarded a $87.6K delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). The contract employs firm fixed pricing and carries an ultimate completion date of November 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order was competitively awarded with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,693.94 on August 20, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 11, 2025. The contract represents a child award under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages in quantities of 30. This is a firm fixed price delivery order with completion scheduled for October 10, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $83,082 on September 15, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 6, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packaging (30-count) on August 8, 2025, with an ultimate completion date of August 29, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract, issued under firm fixed pricing with no set-aside designation, is scheduled for completion by September 24, 2025, and represents a competitive award to support federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). This order, valued at $13,846.97 with a firm fixed price structure, represents a non-competitive, non-set-aside procurement issued under a delivery order contract type and is scheduled for completion by August 18, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (unit dose, 30-count packaging) on August 27, 2025, with a completion date of September 18, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packs (30-count) on August 15, 2025, with a completion date of September 8, 2025. The contract uses firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBKH0Delivery Order
The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for $27,693.94 on September 19, 2025, for the supply of Vyndamax 61 mg capsules (30-count unit dose packaging). This firm fixed-price delivery order, with an ultimate completion date of October 10, 2025, is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is representative of AmerisourceBergen's extensive portfolio of federal pharmaceutical supply contracts with the Defense Logistics Agency's Medical Supply Chain. The company's prime IDV enables the supply of a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major for-profit pharmaceutical distributor registered in the System for Award Management (SAM.gov), AmerisourceBergen demonstrates consistent capability to fulfill federal medical supply requirements through competitive procurement processes with firm fixed-price delivery structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.7k | 9/19/25 |